Search Results - "Fauser, A.A."

Evidence of a Graft-Versus-Leukemia Effect in Chronic Lymphocytic Leukemia After Reduced-Intensity Conditioning and Allogeneic Stem-Cell Transplantation: The Cooperative German Transplant Study Group by SCHETELIG, J, THIEDE, C, HELD, T. K, HÖFFKEN, K, HO, A. D, KIENAST, J, NEUBAUER, A, ZANDER, A. R, FAUSER, A. A, EHNINGER, G, SIEGERT, W, BORNHÄUSER, M, SCHWERDTFEGER, R, KIEHL, M, BEYER, J, SAYER, H. G, KRÖGER, N, HENSEL, M, SCHEFFOLD, C

“…To study whether hematopoietic stem-cell transplantation (HSCT) after reduced-intensity conditioning is effective and tolerable in patients with advanced…”
Get full text

Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience by Basara, N, Kiehl, M.G, Blau, W, Römer, E, Bischoff, M, Schmetzer, B, Kirsten, D, Günzelmann, S, Fauser, A.A

Get full text

Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipients by Kiehl, M.G, Schäfer-Eckart, K, Kröger, M, Bornhäuser, M, Basara, N, Blau, I.W, Kienast, J, Fauser, A.A, Ehninger, G, Armstrong, V.W, Shipkova, M

Get full text

Therapeutic equivalence of single oral doses of dolasetron mesilate and multiple doses of ondansetron for the prevention of emesis after moderately emetogenic chemotherapy by Fauser, A.A., Duclos, B., Chemaissani, A., Del Favero, A., Cognetti, F., Diaz-Rubio, E., Cortes-Funes, H., Conte, P.F., Dressler, H.

“…This multicentre, randomised, double-blind study was designed to compare the anti-emetic efficacy and safety of single oral doses of dolasetron mesilate with…”
Get full text

A controlled randomized study examining the effects of exercise therapy on patients undergoing haematopoietic stem cell transplantation by Baumann, F T, Kraut, L, Schüle, K, Bloch, W, Fauser, A A

“…A haematopoietic SCT (HSCT) can cause severe side effects, which may have a profound impact on a patient's life both physically and psychologically. Some…”
Get full text

Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient by Basara, N, Blau, W.I, Kiehl, M.G, Römer, E, Rudolphi, M, Bischoff, M, Kirsten, D, Sanchez, H, Günzelmann, S, Fauser, A.A

Get full text

120: Long term engraftment after allogeneic transplantation for beta-thalassemia major by Nuernberger, W.A, Thiele, B, Kraut, L, Fauser, A.A

Get full text

Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation by Mohty, Mohamad, Labopin, Myriam, Tabrizzi, Reza, Theorin, Niklas, Fauser, Axel A, Rambaldi, Alessandro, Maertens, Johan, Slavin, Shimon, Majolino, Ignazio, Nagler, Arnon, Blaise, Didier, Rocha, Vanderson, on behalf of Acute Leukemia Working Party

“…1 Service d’Hématologie Clinique, CHU Hôtel Dieu, Université de Nantes, Nantes, France; 2 European Group for Blood and Marrow Transplantation (EBMT), Acute…”
Get full text

Control of nausea and vomiting in patients with fractionated cisplatin chemotherapy: a double-blind randomised study comparing intravenous dolasetron alone and dolasetron plus dexamethasone by Fauser, A.A.

Get full text

Peripheral Blood Stem Cell Transplantation From Unrelated Donors: A Comparison With Marrow Transplantation by Ringdén, O., Remberger, M., Runde, V., Bornhäuser, M., Blau, I.W., Basara, N., Hölig, K., Beelen, D.W., Hägglund, H., Basu, O., Ehninger, G., Fauser, A.A.

“…Peripheral blood stem cell (PBSC) transplants from HLA-A, -B, and -DR compatible unrelated donors (n = 45) were compared with bone marrow (BM; BM group, n =…”
Get full text

Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease by ARNOLD, R, MASSENKEIL, G, KOLB, H. J, KOLBE, K, SAYER, H. G, SCHWERDTFEGER, R, WANDT, H, HOELZER, D, BORNHÄUSER, M, EHNINGER, G, BEELEN, D. W, FAUSER, A. A, HEGENBART, U, HERTENSTEIN, B, HO, A. D, KNAUF, W

“…The feasibility of nonmyeloablative stem cell transplantation (NST) was evaluated in 22 adults with high-risk ALL. 16/22 patients had advanced disease and…”
Get full text

ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML) by ZANDER, A. R, KRÖGER, N, FAUSER, A. A, KIEHL, M, TRENSCHEL, R, OTTINGER, H. D, BERTZ, H, BERGER, J, KOLB, H-J, SCHAEFER, U. W, SCHLEUNING, M, FINKE, J, ZABELINA, T, BEELEN, D, SCHWERDTFEGER, R, BAURMANN, H, BORNHÄUSER, M, EHNINGER, G

“…Matched unrelated donor transplants have an increased risk of severe graft-versus-host disease and transplant-related mortality (TRM). ATG has been introduced…”
Get full text

Peracute onset of severe tumor lysis syndrome immediately after 4 Gy fractionated TBI as part of reduced intensity preparative regimen in a patient with T-ALL with high tumor burden by LINCK, D, BASARA, N, TRAN, V, VUCINIC, V, HERMANN, S, HOELZER, D, FAUSER, A. A

“…We report a 30-year-old patient with therapy-refractory T-ALL undergoing unrelated allogeneic PBSCT. He developed severe tumor lysis syndrome (TLS) with…”
Get full text

MDR1 Gene Expression in NOD/SCID Repopulating Cells after Retroviral Gene Transfer under Clinically Relevant Conditions by Schilz, A.J., Schiedlmeier, B., Kühlcke, K., Fruehauf, S., Lindemann, C., Zeller, W.J., Grez, M., Fauser, A.A., Baum, C., Eckert, H.-G.

“…We have adapted a recently published protocol for retroviral gene transfer into hematopoietic cells [A. J. Schilz et al. (1998) Blood 92: 3163–3171] with…”
Get full text

Eosinophilia in bone marrow after hematopoetic stem cell transplantation: does it indicate the onset of acute graft-versus-host disease? by Koldehoff, M., Schmetzer, B., Roemer, E., Kiehl, M.G., Fauser, A.A., Basara, N.

Get full text

Long-term follow-up of peripheral blood stem cell transplantation from mismatched related and unrelated donors by Blau, I.W, Schmidt-Hieber, M, Basara, N, Hopfenmüller, W, Bischoff, M, Günzelmann, S, Kirsten, D, Schmetzer, B, Roemer, E, Kiehl, M.G, Thiel, E, Fauser, A.A

“…:  Allogeneic stem cell transplantation (SCT) is best performed with an HLA‐identical sibling donor (matched related donor, MRD) to reduce the risk of early…”
Get full text

New therapeutic modalities in the treatment of graft-versus-host disease by Basara, N., Kiehl, M.G., Fauser, A.A.

“…Acute and chronic GvHD are still a major concern in allogeneic hematopoietic stem cell transplantation, still contributing substantially to morbidity and…”
Get full text

Guidelines for anti-emetic therapy: acute emesis by Fauser, A.A., Fellhauer, M., Hoffmann, M., Link, H., Schlimok, G., Gralla, R.J.

“…Anti-emetic therapy has become integral to the management of patients with cancer. Goals related to complete emesis control include providing treatment that…”
Get full text

Allogeneic hematopoietic stem cell transplantation in patients with beta-thalassemia by Zakrzewski, J., Koldehoff, M., Tran, V., Günzelmann, S., Dürr, A., Lentini, G., Nürnberger, W., Basara, N., Kiehl, M., Fauser, A.A.

Get full text

ATG as part of the conditioning regimen reduces transplant-related mortality by Zander, A.R, Kroger, N, Schleuning, M, Finke, J, Zabelina, T, Beelen, D, Schwerdtfeger, R, Baurmann, H, Bornhauser, M, Ehninger, G, Fauser, A.A, Kiehl, M, Trenschel, R, Ottinger, H.D, Bertz, H, Berger, J, Kolb, H.-J, Schaefer, U.W

Get full text